Direct Digital Holdings, Inc. (NASDAQ:DRCT – Get Free Report) was the target of a large increase in short interest during the month of September. As of September 15th, there was short interest totalling 58,700 shares, an increase of 6.0% from the August 31st total of 55,400 shares. Based on an average daily trading volume, of 98,500 shares, the days-to-cover ratio is currently 0.6 days. Currently, 2.0% of the shares of the company are short sold.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Direct Digital stock. Privium Fund Management UK Ltd bought a new stake in shares of Direct Digital Holdings, Inc. (NASDAQ:DRCT – Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 20,925 shares of the company’s stock, valued at approximately $91,000. Privium Fund Management UK Ltd owned about 0.15% of Direct Digital at the end of the most recent quarter. Institutional investors and hedge funds own 4.02% of the company’s stock.
Direct Digital Stock Performance
DRCT opened at $1.99 on Wednesday. The company’s 50-day simple moving average is $3.05 and its two-hundred day simple moving average is $6.03. The stock has a market capitalization of $28.40 million, a P/E ratio of 13.57 and a beta of 7.59. Direct Digital has a 52-week low of $1.90 and a 52-week high of $35.88.
About Direct Digital
Direct Digital Holdings, Inc operates as an end-to-end full-service programmatic advertising platform. The company's platform primarily focuses on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy- and sell-side of the digital advertising ecosystem.
Featured Stories
- Five stocks we like better than Direct Digital
- High Flyers: 3 Natural Gas Stocks for March 2022
- Why Lennar Stock Could Be the Best Play in the Housing Market
- What is the Euro STOXX 50 Index?
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Health Care Stocks Explained: Why You Might Want to Invest
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Direct Digital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direct Digital and related companies with MarketBeat.com's FREE daily email newsletter.